Saturday, December 13, 2025 | 12:22 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India Coronavirus Dispatch: When will a vaccine be ready for use?

Delhi grapples with a third wave, an insight into how the vaccine frontrunners work, fresh research that sheds light on the virus, and more-news on how the country is coping with the pandemic

moderna, covid, vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
premium

Pharmaceutical companies Moderna and Pfizer/BioNTech have spurred optimism that a novel type of vaccine made from messenger RNA, known as mRNA, can offer high levels of protection against Covid-19

Bharath Manjesh New Delhi
When will the top Covid-19 vaccines become available?

Encouraging results on Covid-19 vaccine trials by frontrunners in November have raised hopes that the first generation of coronavirus antidotes is likely to receive approval as soon as December end or early 2021. Ongoing late-stage human trials of mRNA vaccine candidates developed by Pfizer-BioNTech and Moderna Inc have pointed to efficacy rates as high as 95 per cent. 

Russia has also claimed a 92 per cent effectiveness for its Sputnik V vaccine candidate, which is being tested on humans in mid- to late-stage trials by Hyderabad-based Dr Reddy’s Laboratories in India. Of